Lilly and ProQR to Expand RNA Editing Collaboration

December 22, 2022

https://www.globenewswire.com/news-release/2022/12/22/2578418/33039/en/Lilly-and-ProQR-to-Expand-RNA-Editing-Collaboration.html

INDIANAPOLIS; LEIDEN, Netherlands; and CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) — Eli Lilly and Company (NYSE:LLY) and ProQR Therapeutics N.V. (Nasdaq:PRQR), today announced the expansion of their licensing and collaboration agreement focused on the discovery, development and commercialization of new genetic medicines.

Read more at globenewswire.com

Related news for (PRQR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.